Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v1-EN
Language French English
Date Updated 2020-01-17 2019-09-26
Drug Identification Number 02410648 02410648
Brand name MYLAN-TADALAFIL MYLAN-TADALAFIL
Common or Proper name TADALAFIL TADALAFIL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients TADALAFIL TADALAFIL
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28BL 28BL
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-09-25 2019-09-25
Estimated end date 2020-01-17 2019-11-30
Actual end date 2020-01-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments